Cholaman.Inv.&Fn (CHOLAFIN)

FairStock Score: 51/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Strong profit growth of 18.5% showing robust business expansion
• Healthy sales growth of 17.3% indicating good market traction
• Established stalwart status in competitive NBFC sector with Rs 1.5L Cr market cap

Concerns

• High P/E ratio of 30.4 above historical NBFC sector norms
• Low ROCE of 10.3% not exceptional for financial services
• Very low dividend yield of 0.1% provides minimal income

AI Analysis

Cholaman.Inv.&Fn is a Stalwart company — a non-banking financial company that has established itself as a significant player in India's lending sector. Trading at Rs 1,700 per share with a market cap of Rs 1.5 lakh crores, this NBFC shows interesting growth dynamics but faces valuation challenges. The company demonstrates strong operational momentum with profit growth of 18.5% and sales growth of 17.3%, indicating robust business expansion in the competitive financial services landscape. However, analysis suggests caution regarding valuation metrics. The P/E ratio of 30.4 appears elevated for the NBFC sector, where historical norms typically range between 15-25 times earnings. This premium valuation may limit near-term price appreciation potential. The ROCE of 10.3% indicates decent capital efficiency, though not exceptional for a financial services company. The minimal dividend yield of 0.1% suggests management prioritizes reinvestment over shareholder payouts. Data indicates the DhanIQ Score of 2 out of 10 reflects concerns about current risk-reward dynamics. While the company maintains its stalwart status through consistent operations, investors may consider monitoring whether the strong growth trajectory can justify the premium valuation and whether earnings consistency can be maintained in changing economic conditions.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer